MetLife Investment Management’s Illumina ILMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.27M Buy
75,228
+552
+0.7% +$72.5K 0.05% 380
2025
Q4
$9.79M Sell
74,676
-4,397
-6% -$516K 0.05% 360
2025
Q3
$7.51M Sell
79,073
-6,167
-7% -$612K 0.04% 462
2025
Q2
$8.13M Sell
85,240
-2,736
-3% -$222K 0.05% 384
2025
Q1
$6.98M Sell
87,976
-1,442
-2% -$156K 0.04% 459
2024
Q4
$11.9M Buy
89,418
+7,083
+9% +$1.01M 0.06% 218
2024
Q3
$10.7M Sell
82,335
-1,550
-2% -$191K 0.06% 243
2024
Q2
$8.76M Buy
83,885
+43,677
+109% +$4.9M 0.05% 276
2024
Q1
$5.37M Sell
40,208
-1,399
-3% -$188K 0.04% 449
2023
Q4
$5.64M Sell
41,607
-655
-2% -$75.6K 0.04% 392
2023
Q3
$5.64M Sell
42,262
-1,007
-2% -$166K 0.04% 358
2023
Q2
$7.89M Buy
43,269
+1,541
+4% +$312K 0.06% 272
2023
Q1
$9.44M Sell
41,728
-501
-1% -$103K 0.07% 225
2022
Q4
$8.31M Sell
42,229
-639
-1% -$132K 0.06% 247
2022
Q3
$7.96M Sell
42,868
-640
-1% -$127K 0.07% 242
2022
Q2
$7.8M Sell
43,508
-6,711
-13% -$1.71M 0.06% 253
2022
Q1
$17.1M Buy
50,219
+14,718
+41% +$4.97M 0.11% 147
2021
Q4
$13.1M Buy
35,501
+1,438
+4% +$545K 0.11% 149
2021
Q3
$13.4M Sell
34,063
-735
-2% -$338K 0.12% 140
2021
Q2
$16M Sell
34,798
-944
-3% -$380K 0.14% 124
2021
Q1
$13.4M Sell
35,742
-708
-2% -$289K 0.12% 139
2020
Q4
$13.1M Sell
36,450
-1,603
-4% -$511K 0.12% 139
2020
Q3
$11.4M Sell
38,053
-1,471
-4% -$507K 0.13% 146
2020
Q2
$14.2M Buy
39,524
+572
+1% +$184K 0.16% 119
2020
Q1
$10.3M Sell
38,952
-1,192
-3% -$333K 0.14% 134
2019
Q4
$13M Sell
40,144
-980
-2% -$297K 0.14% 140
2019
Q3
$12.2M Sell
41,124
-530
-1% -$156K 0.13% 148
2019
Q2
$14.9M Sell
41,654
-1,303
-3% -$411K 0.16% 117
2019
Q1
$13M Sell
42,957
-259
-0.6% -$75.5K 0.14% 133
2018
Q4
$12.6M Sell
43,216
-744
-2% -$230K 0.15% 121
2018
Q3
$15.7M Sell
43,960
-526
-1% -$169K 0.16% 116
2018
Q2
$12.1M Sell
44,486
-991
-2% -$252K 0.14% 134
2018
Q1
$10.5M Sell
45,477
-962
-2% -$220K 0.12% 159
2017
Q4
$9.87M Buy
+46,439
New +$9.56M 0.11% 171

Other funds holding ILMN

MetLife Investment Management's ILMN Position: Q1 2026 in Review

MetLife Investment Management increased its Illumina (ILMN) stake by 0.74% in Q1 2026, buying an estimated $72.5K and bringing the position to 75,228 shares worth $9.27M. The position accounts for 0.05% of the portfolio, ranked #380.

MetLife Investment Management first reported a position in ILMN in Q4 2017 and has held it in 34 quarters since. The position peaked at $17.1M in Q1 2022. 844 funds tracked by Wall St. Rank hold ILMN as of Q1 2026.

  • MetLife Investment Management held 75,228 shares of Illumina worth $9.27M as of Q1 2026.
  • MetLife Investment Management bought 552 Illumina shares in Q1 2026, an estimated $72.5K.
  • Illumina made up 0.05% of MetLife Investment Management's portfolio in Q1 2026, its #380 holding.
  • MetLife Investment Management first reported a position in Illumina in Q4 2017 and has held it in 34 quarters since.
  • MetLife Investment Management's Illumina position peaked at $17.1M in Q1 2022.
  • 844 funds tracked by Wall St. Rank held Illumina as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.